1 completed, 1 recruiting. 1 Phase 2, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Completed 1 |
| Phase 3 | 1 | Recruiting 1 |
Follow Bigespas LTD: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Efficacy and Safety of DMB-I (INN: Latrepirdine) in Patients With Alzheimer Type Dementia DMB-I (INN: Latrepirdine), Memantine Hydrochloride 20 MG, Placebo - Alzheimer Type Dementia | Phase 3 | Recruiting | Bigespas LTD | 450 | 2025-11-20 | 2025-12-10 |
| DMB-I in the Treatment of Alzheimer Type Dementia DMB-I (Dimebon), Placebo - Alzheimer Disease, Dementia of Alzheimer Type | Phase 2 | Completed | Bigespas LTD | 133 | 2023-12-27 | 2025-03-28 |
latrepirdine (2) · Memantine (1)
Russia (2)